ClinicalTrials.govpublic full text
Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer
lung cancer, recurrent non-small cell lung cancer, stage iiib non-small cell lung cancer, stage iv non-small cell lung cancer, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 838975
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.